Patents

Applications filed and currently pending. Dates are filing dates.

2026

Mar 24, 2026. ecDNA-based biomarker composition for prognostic prediction in multiple myeloma and its use.
Claims extrachromosomal DNA-derived markers for prognostic assessment in multiple myeloma.
Cho H, Jung HE, Kim H. Seoul National University Hospital. Application no. 10-2026-0052951 (Republic of Korea, pending).

Feb 13, 2026. Composition comprising an FcRH5 inhibitor for the prevention or treatment of hematologic malignancies.
Claims compositions containing an FcRH5 inhibitor for use in hematologic malignancies.
Cho H, Byun JM, Kim J. Seoul National University Hospital. Application no. 10-2026-0029649 (Republic of Korea, pending).

2025

Sep 5, 2025. Pharmaceutical composition for the prevention or treatment of cancer.
Cho H, Kim S, Kwak J-E. Yonsei University Health System. Application no. 10-2025-0126501 (Republic of Korea, pending).